News

Ideas That Generate Results

Strategic Alliances Offer Breakthrough Advancements in microRNA Based Diagnostic Programs

Nov 18, 2015

Share |
According to a new research report by RNCOS entitled, “Global miRNA Market Outlook to 2020”, various strategic alliances and collaborations are taking place in the miRNA research for the product development, resulting in novel kits for qPCR and new mimics and inhibitors that help researchers in completion of project before time and also in receiving more funding Market players are entering into such strategic activity to primarily build up on the resources available to them and gain faster research outcomes by utilizing technical skills of other market players. For instance, Regulus Therapeutics entered into a strategic alliance with AstraZeneca for the discovery, development, and commercialization of microRNA therapeutics. Also, Regulus Therapeutics declared a new collaboration agreement with Biogen Idec to expand its research focused on identifying microRNAs as biomarkers for multiple sclerosis under its Regulus micro Markers division.
 
Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application of miRNA is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.
 
The report takes into account all the key aspects of the worldwide miRNA market, including the present and future outlook of the miRNA based tools and service segments and projects the market during the period 2015-2020 for the regions i.e. the Americas, Europe, and Asia Pacific. It prudently analyzes all the industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performance and last but not the least, current and future market size. Moreover, the report provides a brief summary of the recent trends that may have an impact on the future industry performance. The report also provides in depth analysis of the end users of miRNA market. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM787.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
 


Media Citation

get in touch

Please fill-in the information below.